Clin2
NCT07223489Possibly a fitRecruiting

Understanding Adult SMA Diagnosis & Treatment Experiences

Spinal Muscular Atrophy (SMA)

Part of Brain & nervous system clinical trials.

This trial explores the experiences of adults with spinal muscular atrophy (SMA) in the MedStar Health System, looking at how they are diagnosed and treated, and any differences in care they may face.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must have a diagnosis of spinal muscular atrophy (SMA).
  • You must be 18 years old or older.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06978985Recruiting
Adult SMA research and clinical hub study

This study creates a registry and clinical hub for adults with 5q spinal muscular atrophy (SMA). It aims to track health outcomes and improve care for people living with SMA.

Birmingham
NCT06977269Recruiting
Brain stimulation safety study for spinal muscular atrophy

This trial tests whether a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) is safe and tolerable for people with spinal muscular atrophy (SMA). It may help improve muscle function by activating low motor neurons.

Kharkiv, Kharkiv Oblast
NCT07332702Recruiting
Spinal muscular atrophy gene study

This study looks at changes in two genes, SMN1 and SMN2, which are linked to spinal muscular atrophy (SMA). It aims to better understand the different versions of these genes in healthy people and those with SMA. Participating involves a blood sample and genetic analysis.

Rouen
NCT06888661Enrolling by invitation· Early Phase 1
Testing EXG001-307 for spinal muscular atrophy in infants

This trial tests a new medicine called EXG001-307 for babies with spinal muscular atrophy (SMA) types 1 and 2. The goal is to see if it is safe and helps with muscle strength and breathing.

Shanghai, Shanghai Municipality
NCT07543003Recruiting
Wearable Monitoring for Young Children With Spinal Muscular Atrophy

This study uses wearable devices (like smartwatches or activity trackers) to monitor movement and motor development in young children with spinal muscular atrophy (SMA), a rare genetic condition affecting muscle strength. The goal is to see if wearables can track disease progression and treatment response better than traditional clinic visits.

Oxford
NCT07578454Recruiting
Virtual reality rehabilitation for spinal muscular atrophy

This study tests a virtual reality rehabilitation program for young people with SMA (spinal muscular atrophy, a genetic muscle-weakening condition). Researchers want to understand if VR-based exercises can help improve function and quality of life.

Oxford

Hear when a new Spinal Muscular Atrophy (SMA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.